Limits...
Combination of platelet-rich plasma and bone marrow mesenchymal stem cells enhances tendon – bone healing in a rabbit model of anterior cruciate ligament reconstruction

View Article: PubMed Central - PubMed

ABSTRACT

Background: The objective of this study was to investigate the potency of platelet-rich plasma (PRP) combined with bone marrow mesenchymal stem cells (BMSCs) to promote tendon–bone healing in a rabbit model.

Methods: In the in vitro study, the effects of PRP on osteogenic induction of BMSCs were analysed. Later, PRP with or without BMSCs was used in the rabbit model of anterior cruciate ligament reconstruction. Specimens were harvested 8 weeks postoperatively to evaluate tendon–bone healing by histology, radiology, and biomechanical testing.

Results: The in vitro study revealed that collagen I, osteocalcin, and osteopontin expression was higher in BMSCs co-cultured with PRP for 14 days. The in vivo study revealed a more mature tendon–bone interface using light microscopy, a more newly formed bone at the bone tunnel walls detected by micro-computed tomography, and a significantly higher failure load as assessed by biomechanical testing in the BMSC + PRP group than in the control and PRP groups.

Conclusions: These results indicate that the combination of PRP and BMSCs promotes tendon–bone healing and has potential for clinical use.

Electronic supplementary material: The online version of this article (doi:10.1186/s13018-016-0433-7) contains supplementary material, which is available to authorized users.

No MeSH data available.


Reverse transcription–polymerase chain reaction evaluation of osteogenic gene mRNA expression. Asterisk indicates significant difference (p < 0.05) compared with gene expression levels of BMSCs co-cultured with or without platelet-rich plasma (PRP) a collagen I; b osteocalcin (OCN); c osteopontin (OPN)
© Copyright Policy - OpenAccess
Related In: Results  -  Collection

License 1 - License 2
getmorefigures.php?uid=PMC5015347&req=5

Fig5: Reverse transcription–polymerase chain reaction evaluation of osteogenic gene mRNA expression. Asterisk indicates significant difference (p < 0.05) compared with gene expression levels of BMSCs co-cultured with or without platelet-rich plasma (PRP) a collagen I; b osteocalcin (OCN); c osteopontin (OPN)

Mentions: The transcription of osteogenic genes, including collagen I, osteocalcin, and osteopontin, was evaluated by real-time quantitative reverse transcription–polymerase chain reaction (RT-PCR) analysis. Collagen I, osteocalcin, and osteopontin messenger RNA (mRNA) levels in BMSCs increased gradually after co-culture with PRP. The levels of the three osteogenic genes were significantly higher than those in uninduced BMSCs at all time points (p < 0.05, Fig. 5).Fig. 5


Combination of platelet-rich plasma and bone marrow mesenchymal stem cells enhances tendon – bone healing in a rabbit model of anterior cruciate ligament reconstruction
Reverse transcription–polymerase chain reaction evaluation of osteogenic gene mRNA expression. Asterisk indicates significant difference (p < 0.05) compared with gene expression levels of BMSCs co-cultured with or without platelet-rich plasma (PRP) a collagen I; b osteocalcin (OCN); c osteopontin (OPN)
© Copyright Policy - OpenAccess
Related In: Results  -  Collection

License 1 - License 2
Show All Figures
getmorefigures.php?uid=PMC5015347&req=5

Fig5: Reverse transcription–polymerase chain reaction evaluation of osteogenic gene mRNA expression. Asterisk indicates significant difference (p < 0.05) compared with gene expression levels of BMSCs co-cultured with or without platelet-rich plasma (PRP) a collagen I; b osteocalcin (OCN); c osteopontin (OPN)
Mentions: The transcription of osteogenic genes, including collagen I, osteocalcin, and osteopontin, was evaluated by real-time quantitative reverse transcription–polymerase chain reaction (RT-PCR) analysis. Collagen I, osteocalcin, and osteopontin messenger RNA (mRNA) levels in BMSCs increased gradually after co-culture with PRP. The levels of the three osteogenic genes were significantly higher than those in uninduced BMSCs at all time points (p < 0.05, Fig. 5).Fig. 5

View Article: PubMed Central - PubMed

ABSTRACT

Background: The objective of this study was to investigate the potency of platelet-rich plasma (PRP) combined with bone marrow mesenchymal stem cells (BMSCs) to promote tendon&ndash;bone healing in a rabbit model.

Methods: In the in vitro study, the effects of PRP on osteogenic induction of BMSCs were analysed. Later, PRP with or without BMSCs was used in the rabbit model of anterior cruciate ligament reconstruction. Specimens were harvested 8&nbsp;weeks postoperatively to evaluate tendon&ndash;bone healing by histology, radiology, and biomechanical testing.

Results: The in vitro study revealed that collagen I, osteocalcin, and osteopontin expression was higher in BMSCs co-cultured with PRP for 14&nbsp;days. The in vivo study revealed a more mature tendon&ndash;bone interface using light microscopy, a more newly formed bone at the bone tunnel walls detected by micro-computed tomography, and a significantly higher failure load as assessed by biomechanical testing in the BMSC + PRP group than in the control and PRP groups.

Conclusions: These results indicate that the combination of PRP and BMSCs promotes tendon&ndash;bone healing and has potential for clinical use.

Electronic supplementary material: The online version of this article (doi:10.1186/s13018-016-0433-7) contains supplementary material, which is available to authorized users.

No MeSH data available.